NEWS

Generate and sustain interest through hands-on workshops and experiments

MINTworld is the result of a collaboration between Lonza and the Department of Economy and Education (DEF) of the Canton of Valais. The aim of this discovery and innovation center in Visp is to raise awareness among compulsory school pupils and young people of innovation in the fields of mathematics, computer science, natural sciences and …

Generate and sustain interest through hands-on workshops and experiments Read More »

Valais’ chemical-pharmaceutical sector in top form

Published today in the Bilan Magazine, discover the excellent overview written by Vincent Gilloz on the chemical-pharmaceutical sector good health. “The recent celebration of Valsynthèse’s 40th anniversary in Brigues, the ground-breaking ceremony for Debiopharm’s new building in Martigny and the inauguration of BioArk’s third center in Monthey are reminders of the sector’s excellent health in …

Valais’ chemical-pharmaceutical sector in top form Read More »

Stämm’s Vision for Biomanufacturing 4.0 at BioArk Monthey

As a resident of the BioArk technological site in Monthey, Stämm is pioneering innovations that redefine biomanufacturing. Their insights into Biomanufacturing 4.0 highlight a transformative approach that integrates cutting-edge technologies to enhance efficiency and sustainability.

Navigating the Digital Frontier

👉 𝑵𝒂𝒗𝒊𝒈𝒂𝒕𝒊𝒏𝒈 𝒕𝒉𝒆 𝑫𝒊𝒈𝒊𝒕𝒂𝒍 𝑭𝒓𝒐𝒏𝒕𝒊𝒆𝒓: Highlights from a Day of Insightful Discourse on Digital Technologies in Biotech and Biopharma event on Campus Energypolis. It was an amazing opportunity to learn from experts and peers in the D-A-CH region about how digitalization, data science, artificial intelligence (AI), and machine learning (ML) are transforming biotechnology and biopharma.

Cancer Research: CHF 1.1 Million for Novochizol SA

EPFL and Novochizol SA to collaborate on designing more efficient immunotherapies, with the support of Innosuisse, the Swiss Innovation Agency. The EPFL Laboratory of Biomaterials for Immunoengineering, headed by Prof. Li Tang, and the BioArk Monthey– hosted startup company Novochizol SA possessing a unique chitosan transformation technology, today announced that Innosuisse will co-fund their collaborative …

Cancer Research: CHF 1.1 Million for Novochizol SA Read More »

Scroll to Top